We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$251M
AUM Growth
+$17.5M
Cap. Flow
+$12.1M
Cap. Flow %
4.81%
Top 10 Hldgs %
73.45%
Holding
118
New
10
Increased
17
Reduced
7
Closed
9
Avg Time Held
1.9 years
Top 10 Avg Time Held
2 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
MIC icon
Macquarie Infrastructure Holdings, LLC
MIC
+$8.13M
2
FTAI icon
FTAI Aviation
FTAI
+$4.74M
3
UPLD icon
Upland Software
UPLD
+$3.95M
4
VKTX icon
Viking Therapeutics
VKTX
+$674K
5
QTNT
Quotient Limited Ordinary Shares
QTNT
+$476K

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$4.88M
2
PFE icon
Pfizer
PFE
+$1.63M
3
ATCO
Atlas Corp.
ATCO
+$993K
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$752K
5
SHPG
Shire pic
SHPG
+$460K

Sector Composition

Rank Sector Weight
1 Healthcare 64.78%
2 Financials 7.67%
3 Technology 5.89%
4 Energy 5.67%
5 Industrials 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
STML
26
DELISTED
Stemline Therapeutics, Inc.
STML
$1.17M 0.47%
74,992
– –
2017 Q1
3 quarters
CNQ icon
27
Canadian Natural Resources
CNQ
$111B
$1.16M 0.46%
66,059
– –
2017 Q2
2 quarters
JNJ icon
28
Johnson & Johnson
JNJ
$616B
$1.02M 0.4%
7,280
– –
2013 Q2
18 quarters
APO icon
29
Apollo Global Management
APO
$65.5B
$1M 0.4%
30,000
– –
2017 Q2
2 quarters
DOC icon
30
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1M 0.4%
55,800
– –
2013 Q3
17 quarters
VZ icon
31
Verizon
VZ
$186B
$969K 0.39%
18,311
– –
2014 Q2
14 quarters
IMMU
32
DELISTED
Immunomedics Inc
IMMU
$945K 0.38%
58,483
-7,000
-11% -$82.6K
2017 Q1
3 quarters
VKTX icon
33
Viking Therapeutics
VKTX
$3.18B
$942K 0.37%
+232,000
New +$674K
2017 Q4
0 quarters
XRN.PRA icon
34
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$75M
$886K 0.35%
35,000
– –
2017 Q3
1 quarter
T icon
35
AT&T
T
$161B
$858K 0.34%
29,194
– –
2014 Q2
14 quarters
RHP icon
36
Ryman Hospitality Properties
RHP
$8.73B
$856K 0.34%
12,400
– –
2013 Q2
18 quarters
GSK icon
37
GSK
GSK
$99.4B
$802K 0.32%
18,080
– –
2014 Q4
12 quarters
FF icon
38
Future Fuel
FF
$244M
$772K 0.31%
54,804
– –
2013 Q2
18 quarters
SVC
39
Service Properties Trust
SVC
$794M
$746K 0.3%
5,000
– –
2015 Q1
11 quarters
KMB icon
40
Kimberly-Clark
KMB
$35.1B
$724K 0.29%
6,000
– –
2017 Q3
1 quarter
DERM icon
41
DELISTED
Dermira, Inc.
DERM
$721K 0.29%
25,936
+1,900
+8% +$50.4K
2017 Q2
2 quarters
GILD icon
42
Gilead Sciences
GILD
$193B
$709K 0.28%
9,901
-519
-5% -$39.4K
2015 Q4
8 quarters
GE icon
43
GE Aerospace
GE
$326B
$706K 0.28%
7,028
+1,044
+17% +$99.7K
2013 Q2
18 quarters
WY icon
44
Weyerhaeuser
WY
$14.2B
$705K 0.28%
20,000
– –
2017 Q2
2 quarters
ARNA
45
DELISTED
Arena Pharmaceuticals Inc
ARNA
$681K 0.27%
20,042
+400
+2% +$11.4K
2017 Q3
1 quarter
MDLZ icon
46
Mondelez International
MDLZ
$81.8B
$680K 0.27%
15,900
– –
2013 Q2
18 quarters
UAL icon
47
United Airlines
UAL
$31.2B
$674K 0.27%
10,000
– –
2017 Q3
1 quarter
IBM icon
48
IBM
IBM
$218B
$657K 0.26%
4,481
– –
2015 Q1
11 quarters
SBCP
49
DELISTED
Sunshine Bancorp, Inc
SBCP
$638K 0.25%
27,800
– –
2014 Q3
13 quarters
XRN icon
50
Chiron Real Estate Inc
XRN
$401M
$631K 0.25%
15,400
– –
2016 Q2
6 quarters
1
2
3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q4 2017 Portfolio in Review

As of Q4 2017, David M. Knott held 118 positions worth $251M, up 7.5% from $234M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

David M. Knott deployed $12.1M of net new capital in Q4 2017, opening 10 new positions and adding to 17 existing holdings. Its largest new stake was FTAI Aviation: 302,001 shares worth $5.14M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, down from 70% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $4.88M trimmed.

  • David M. Knott's largest Q4 2017 buy was FTAI Aviation: 302,001 shares worth $5.14M.
  • David M. Knott added most to Macquarie Infrastructure Holdings, LLC in Q4 2017, an estimated $8.13M increase.
  • David M. Knott's biggest Q4 2017 reduction was Ligand Pharmaceuticals, cutting an estimated $4.88M.
  • David M. Knott fully exited Atlas Corp. in Q4 2017, selling an estimated $993K.
  • David M. Knott's ten largest holdings make up 73% of its $251M portfolio in Q4 2017.
  • David M. Knott opened 10 new positions and closed 9 in Q4 2017.
  • David M. Knott's portfolio value rose 7.5% quarter-over-quarter to $251M.

Based on David M. Knott's 13F filing for Q4 2017, filed 13 Feb 2018.